full test bank for
pharmacology a patient-centered nursing process approach, 11th
edition
by linda e. mccuistion | verified chapter's 1 - 58 | complete answers
,table of contents
chapter 01: the nursing process and patient-centered care ................................. 5
chapter 02: drug development and ethical considerations ................................ 13
chapter 03: pharmacokinetics and pharmacodynamics ..................................... 27
chapter 04: pharmacogenetics .......................................................................... 50
chapter 05: complementary and alternative therapies ...................................... 56
chapter 06: pediatric considerations ................................................................. 64
chapter 07: geriatric considerations .................................................................. 76
chapter 08: drugs in substance use disorder ...................................................... 85
chapter 09: safety and quality........................................................................... 94
chapter 10: drug administration ..................................................................... 104
chapter 11: drug calculations .......................................................................... 113
chapter 12: fluid volume and electrolytes ....................................................... 121
chapter 13: vitamin and mineral replacement................................................. 135
chapter 14: nutritional support ....................................................................... 147
chapter 15: adrenergic agonists and antagonists ............................................ 159
chapter 16: cholinergic agonists and antagonists............................................ 169
chapter 17: stimulants .................................................................................... 179
chapter 18: depressants .................................................................................. 187
chapter 19: antiseizure drugs .......................................................................... 197
chapter 20: drugs for parkinsonism and alzheimer disease ............................. 209
chapter 21: drugs for neuromuscular disorders and muscle spasms ................ 220
chapter 22: antipsychotics and anxiolytics ...................................................... 229
chapter 23: antidepressants and mood stabilizers........................................... 241
chapter 24: antiinflammatories....................................................................... 253
chapter 25: analgesics .................................................................................... 265
chapter 26: penicillins, other beta-lactams, and cephalosporins ..................... 276
,chapter 27: macrolides, oxazolidinones, lincosamides, glycopeptides, ketolides,
and lipopeptides ............................................................................................. 285
chapter 28: tetracyclines, glycylcyclines, aminoglycosides, and fluoroquinolones
....................................................................................................................... 291
chapter 29: sulfonamides and nitroimidazoles antibiotics ............................... 298
chapter 30: antituberculars, antifungals, and antivirals .................................. 305
chapter 31: antimalarials, anthelmintics, and peptides ................................... 319
chapter 32: hiv- and aids-related drugs ........................................................... 324
chapter 33: transplant drugs ........................................................................... 331
chapter 34: vaccines........................................................................................ 335
chapter 35: anticancer drugs........................................................................... 342
chapter 36: targeted therapies to treat cancer ................................................ 350
chapter 37: biologic response modifiers .......................................................... 356
chapter 38: upper respiratory disorders .......................................................... 364
chapter 39: lower respiratory disorders .......................................................... 373
chapter 40: cardiac glycosides, antianginals, and antidysrhythmics ................ 384
chapter 41: diuretics ....................................................................................... 399
chapter 42: antihypertensives ......................................................................... 407
chapter 43: anticoagulants, antiplatelets, and thrombolytics ......................... 418
chapter 44: antihyperlipidemics and drugs to improve peripheral blood flow . 432
chapter 45: gastrointestinal tract disorders .................................................... 442
chapter 46: antiulcer drugs ............................................................................. 455
chapter 47: eye and ear disorders ................................................................... 466
chapter 48: dermatologic disorders................................................................. 473
chapter 49: pituitary, thyroid, parathyroid, and adrenal disorders .................. 482
chapter 50: antidiabetics ................................................................................ 497
chapter 51: urinary disorders .......................................................................... 510
chapter 52: pregnancy and preterm labor ....................................................... 520
,chapter 53: labor, delivery, and postpartum ................................................... 533
chapter 54: neonatal and newborn ................................................................. 543
chapter 55: women’s reproductive health ....................................................... 546
chapter 56: men’s health and reproductive disorders ...................................... 558
chapter 57: sexually transmitted infections ..................................................... 567
chapter 58: adult and pediatric emergency drugs ........................................... 572
,chapter 01: the nursing process and patient-centered care
mccuistion: pharmacology: a patient-centered nursing
process approach, 11th edition
multiple choice
1. all of the following would be considered subjective data, except:
a. patient-reported health history
b. patient-reported signs and symptoms of their illness
c. financial barriers reported by the patient’s caregiver
d. vital signs obtained from the medical record
answer>>d
subjective data is based on what patients or family members communicate to
the nurse. patient- reported health history, signs and symptoms, and caregiver
reported financial barriers would be considered subjective data. vital signs
obtained from the medical record would be considered objective data.
dif: cognitive level: understanding (comprehension) top: nursing process:
planning msc: nclex: management of client care
2. the nurse is using data collected to define a set of interventions to achieve
the most desirable outcomes. which of the following steps is the nurse applying?
a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
c. generate solutions (planning)
d. take action (nursing interventions)
answer>>c
,when generating solutions (planning), the nurse identifies expected outcomes
and uses the patient’s problem(s) to define a set of interventions to achieve the
most desirable outcomes. recognizing cues (assessment) involves the gathering
of cues (information) from the patient about their health and lifestyle practices,
which are important facts that aid the nurse in making clinical care decisions.
prioritizing hypothesis is used to organize and rank the patient problem(s)
identified. finally, taking action involves implementation of nursing
interventions to accomplish the expected outcomes.
dif: cognitive level: understanding (comprehension) top: nursing process:
nursing intervention
msc: nclex: management of client care
3. a 5-year-old child with type 1 diabetes mellitus has had repeated
hospitalizations for episodes of hyperglycemia. the parents tell the nurse that
they can’t keep track of everything that has to be done to care for their child.
the nurse reviews medications, diet, and symptom management with the
parents and draws up a daily checklist for the family to use. these activities are
completed in which step of the nursing process?
a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
d. take action (nursing interventions)
answer>>d
taking action through nursing interventions is where the nurse provides patient
health teaching, drug administration, patient care, and other interventions
necessary to assist the patient in accomplishing expected outcomes.
dif: cognitive level: understanding (comprehension) top: nursing process:
nursing intervention
msc: nclex: management of client care
4. the nurse is preparing to administer a medication and reviews the
patient’s chart for drug allergies, serum creatinine, and blood urea nitrogen
(bun) levels. the nurse’s actions are reflective of which of the following?
, a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
c. take action (nursing interventions)
d. generate solutions (planning)
answer>>a
recognizing cues (assessment) involves gathering subjective and objective
information about the patient and the medication. laboratory values from the
patient’s chart would be considered collection of objective data.
dif: cognitive level: understanding (comprehension)
top: nursing process: assessment msc: nclex: management of client care
5. which of the following would be correctly categorized as objective data?
a. a list of herbal supplements regularly used provided by the patient.
b. lab values associated with the drugs the patient is taking.
c. the ages and relationship of all household members to the patient.
d. usual dietary patterns and food intake.
answer>>b
objective data are measured and detected by another person and would include
lab values. the other examples are subjective data.
dif: cognitive level: understanding (comprehension)
top: nursing process: assessment msc: nclex: management of client care
6. the nurse reviews a patient’s database and learns that the patient lives
alone, is forgetful, and does not have an established routine. the patient will be
sent home with three new medications to be taken at different times of the day.
the nurse develops a daily medication chart and enlists a family member to put
the patient’s pills in a pill organizer. this is an example of which element of the
nursing process?
a. recognizing cues (assessment)
pharmacology a patient-centered nursing process approach, 11th
edition
by linda e. mccuistion | verified chapter's 1 - 58 | complete answers
,table of contents
chapter 01: the nursing process and patient-centered care ................................. 5
chapter 02: drug development and ethical considerations ................................ 13
chapter 03: pharmacokinetics and pharmacodynamics ..................................... 27
chapter 04: pharmacogenetics .......................................................................... 50
chapter 05: complementary and alternative therapies ...................................... 56
chapter 06: pediatric considerations ................................................................. 64
chapter 07: geriatric considerations .................................................................. 76
chapter 08: drugs in substance use disorder ...................................................... 85
chapter 09: safety and quality........................................................................... 94
chapter 10: drug administration ..................................................................... 104
chapter 11: drug calculations .......................................................................... 113
chapter 12: fluid volume and electrolytes ....................................................... 121
chapter 13: vitamin and mineral replacement................................................. 135
chapter 14: nutritional support ....................................................................... 147
chapter 15: adrenergic agonists and antagonists ............................................ 159
chapter 16: cholinergic agonists and antagonists............................................ 169
chapter 17: stimulants .................................................................................... 179
chapter 18: depressants .................................................................................. 187
chapter 19: antiseizure drugs .......................................................................... 197
chapter 20: drugs for parkinsonism and alzheimer disease ............................. 209
chapter 21: drugs for neuromuscular disorders and muscle spasms ................ 220
chapter 22: antipsychotics and anxiolytics ...................................................... 229
chapter 23: antidepressants and mood stabilizers........................................... 241
chapter 24: antiinflammatories....................................................................... 253
chapter 25: analgesics .................................................................................... 265
chapter 26: penicillins, other beta-lactams, and cephalosporins ..................... 276
,chapter 27: macrolides, oxazolidinones, lincosamides, glycopeptides, ketolides,
and lipopeptides ............................................................................................. 285
chapter 28: tetracyclines, glycylcyclines, aminoglycosides, and fluoroquinolones
....................................................................................................................... 291
chapter 29: sulfonamides and nitroimidazoles antibiotics ............................... 298
chapter 30: antituberculars, antifungals, and antivirals .................................. 305
chapter 31: antimalarials, anthelmintics, and peptides ................................... 319
chapter 32: hiv- and aids-related drugs ........................................................... 324
chapter 33: transplant drugs ........................................................................... 331
chapter 34: vaccines........................................................................................ 335
chapter 35: anticancer drugs........................................................................... 342
chapter 36: targeted therapies to treat cancer ................................................ 350
chapter 37: biologic response modifiers .......................................................... 356
chapter 38: upper respiratory disorders .......................................................... 364
chapter 39: lower respiratory disorders .......................................................... 373
chapter 40: cardiac glycosides, antianginals, and antidysrhythmics ................ 384
chapter 41: diuretics ....................................................................................... 399
chapter 42: antihypertensives ......................................................................... 407
chapter 43: anticoagulants, antiplatelets, and thrombolytics ......................... 418
chapter 44: antihyperlipidemics and drugs to improve peripheral blood flow . 432
chapter 45: gastrointestinal tract disorders .................................................... 442
chapter 46: antiulcer drugs ............................................................................. 455
chapter 47: eye and ear disorders ................................................................... 466
chapter 48: dermatologic disorders................................................................. 473
chapter 49: pituitary, thyroid, parathyroid, and adrenal disorders .................. 482
chapter 50: antidiabetics ................................................................................ 497
chapter 51: urinary disorders .......................................................................... 510
chapter 52: pregnancy and preterm labor ....................................................... 520
,chapter 53: labor, delivery, and postpartum ................................................... 533
chapter 54: neonatal and newborn ................................................................. 543
chapter 55: women’s reproductive health ....................................................... 546
chapter 56: men’s health and reproductive disorders ...................................... 558
chapter 57: sexually transmitted infections ..................................................... 567
chapter 58: adult and pediatric emergency drugs ........................................... 572
,chapter 01: the nursing process and patient-centered care
mccuistion: pharmacology: a patient-centered nursing
process approach, 11th edition
multiple choice
1. all of the following would be considered subjective data, except:
a. patient-reported health history
b. patient-reported signs and symptoms of their illness
c. financial barriers reported by the patient’s caregiver
d. vital signs obtained from the medical record
answer>>d
subjective data is based on what patients or family members communicate to
the nurse. patient- reported health history, signs and symptoms, and caregiver
reported financial barriers would be considered subjective data. vital signs
obtained from the medical record would be considered objective data.
dif: cognitive level: understanding (comprehension) top: nursing process:
planning msc: nclex: management of client care
2. the nurse is using data collected to define a set of interventions to achieve
the most desirable outcomes. which of the following steps is the nurse applying?
a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
c. generate solutions (planning)
d. take action (nursing interventions)
answer>>c
,when generating solutions (planning), the nurse identifies expected outcomes
and uses the patient’s problem(s) to define a set of interventions to achieve the
most desirable outcomes. recognizing cues (assessment) involves the gathering
of cues (information) from the patient about their health and lifestyle practices,
which are important facts that aid the nurse in making clinical care decisions.
prioritizing hypothesis is used to organize and rank the patient problem(s)
identified. finally, taking action involves implementation of nursing
interventions to accomplish the expected outcomes.
dif: cognitive level: understanding (comprehension) top: nursing process:
nursing intervention
msc: nclex: management of client care
3. a 5-year-old child with type 1 diabetes mellitus has had repeated
hospitalizations for episodes of hyperglycemia. the parents tell the nurse that
they can’t keep track of everything that has to be done to care for their child.
the nurse reviews medications, diet, and symptom management with the
parents and draws up a daily checklist for the family to use. these activities are
completed in which step of the nursing process?
a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
d. take action (nursing interventions)
answer>>d
taking action through nursing interventions is where the nurse provides patient
health teaching, drug administration, patient care, and other interventions
necessary to assist the patient in accomplishing expected outcomes.
dif: cognitive level: understanding (comprehension) top: nursing process:
nursing intervention
msc: nclex: management of client care
4. the nurse is preparing to administer a medication and reviews the
patient’s chart for drug allergies, serum creatinine, and blood urea nitrogen
(bun) levels. the nurse’s actions are reflective of which of the following?
, a. recognizing cues (assessment)
b. analyze cues & prioritize hypothesis (analysis)
c. take action (nursing interventions)
d. generate solutions (planning)
answer>>a
recognizing cues (assessment) involves gathering subjective and objective
information about the patient and the medication. laboratory values from the
patient’s chart would be considered collection of objective data.
dif: cognitive level: understanding (comprehension)
top: nursing process: assessment msc: nclex: management of client care
5. which of the following would be correctly categorized as objective data?
a. a list of herbal supplements regularly used provided by the patient.
b. lab values associated with the drugs the patient is taking.
c. the ages and relationship of all household members to the patient.
d. usual dietary patterns and food intake.
answer>>b
objective data are measured and detected by another person and would include
lab values. the other examples are subjective data.
dif: cognitive level: understanding (comprehension)
top: nursing process: assessment msc: nclex: management of client care
6. the nurse reviews a patient’s database and learns that the patient lives
alone, is forgetful, and does not have an established routine. the patient will be
sent home with three new medications to be taken at different times of the day.
the nurse develops a daily medication chart and enlists a family member to put
the patient’s pills in a pill organizer. this is an example of which element of the
nursing process?
a. recognizing cues (assessment)
